Treating myocardial infarction in the post-GUSTO era. A US perspective.
Publication
, Journal Article
Mark, DB
Published in: Pharmacoeconomics
June 1996
Duke Scholars
Published In
Pharmacoeconomics
DOI
ISSN
1170-7690
Publication Date
June 1996
Volume
9
Issue
6
Start / End Page
473 / 477
Location
New Zealand
Related Subject Headings
- Tissue Plasminogen Activator
- Plasminogen Activators
- Myocardial Infarction
- Humans
- Health Policy & Services
- 4203 Health services and systems
- 3801 Applied economics
- 3214 Pharmacology and pharmaceutical sciences
- 14 Economics
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Mark, D. B. (1996). Treating myocardial infarction in the post-GUSTO era. A US perspective. Pharmacoeconomics, 9(6), 473–477. https://doi.org/10.2165/00019053-199609060-00001
Mark, D. B. “Treating myocardial infarction in the post-GUSTO era. A US perspective.” Pharmacoeconomics 9, no. 6 (June 1996): 473–77. https://doi.org/10.2165/00019053-199609060-00001.
Mark DB. Treating myocardial infarction in the post-GUSTO era. A US perspective. Pharmacoeconomics. 1996 Jun;9(6):473–7.
Mark, D. B. “Treating myocardial infarction in the post-GUSTO era. A US perspective.” Pharmacoeconomics, vol. 9, no. 6, June 1996, pp. 473–77. Pubmed, doi:10.2165/00019053-199609060-00001.
Mark DB. Treating myocardial infarction in the post-GUSTO era. A US perspective. Pharmacoeconomics. 1996 Jun;9(6):473–477.
Published In
Pharmacoeconomics
DOI
ISSN
1170-7690
Publication Date
June 1996
Volume
9
Issue
6
Start / End Page
473 / 477
Location
New Zealand
Related Subject Headings
- Tissue Plasminogen Activator
- Plasminogen Activators
- Myocardial Infarction
- Humans
- Health Policy & Services
- 4203 Health services and systems
- 3801 Applied economics
- 3214 Pharmacology and pharmaceutical sciences
- 14 Economics
- 11 Medical and Health Sciences